Back to Clinical Feed
Try:
Front ImmunolInfectious Disease
Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis
26 May 20264 min read0 viewsJournal Feed
GIST (Key Takeaways)
- Background. Gouty arthritis (GA) has long been considered a disease primarily driven by innate immune activation, whereas the contribution of adaptive immune remodeling remains incompletely understood.
- Methods. In this study, we integrated bidirectional Mendelian randomization (MR), CyTOF immune profiling, single-cell transcriptomic analysis, plasma proteomics, and prospective clinical follow-up analyses to investigate immune-associated features and recurrence-related inflammatory signatures in acute GA.
- Bidirectional two-sample MR analyses were performed using publicly available European ancestry GWAS datasets to evaluate genetic association patterns between 731 immune cell phenotypes and gout. Peripheral immune remodeling was subsequently characterized in Chinese cohorts using CyTOF analysis of PBMC samples from GA-A (n = 25), GA-R (n = 22), and healthy controls (n = 9), together with re-analysis of a public PBMC-derived single-cell RNA-seq dataset.
- Cell-cell communication, pathway enrichment, and differential expression analyses were performed to explore inflammatory programs associated with acute flares.
Clinical Editorial
Summary
Frontiers in Immunology published a clinical update in Infectious Disease on 26 May 2026.
The item focuses on Peripheral CD4+ naïve T cell remodeling and MMP1-associated inflammatory signatures in acute gouty arthritis.
Review the original article for the full source wording and details.
Source Reference
Read the full original publication from the source journal or publisher link below.
Related by Condition/Drug
Front ImmunolRelated by Conditionarthritis
Integrating genetic, epigenetic, and clinical signatures via machine learning for robust prediction of leflunomide response in rheumatoid arthritis: a multi-center validation study
Infectious Disease • 24 Jun 2026
Front ImmunolRelated by Conditionarthritis
Identification and experimental validation of CD74, PGLYRP1, and TXN as potential biomarkers in rheumatoid arthritis: an integrative bulk and ScRNA-seq study
Infectious Disease • 23 Jun 2026
Nat ImmunolRelated by Conditionarthritis
Why regulatory T cells fail to control inflammation in rheumatoid arthritis
Infectious Disease • 18 Jun 2026
Nat ImmunolRelated by Conditionarthritis
Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases
Infectious Disease • 16 Jun 2026
ClinicalTrialsRelated by Conditionarthritis
Protocol For The Feasibility Study Of INSPIRE: Informal Caregivers Of Frail RA Patients
Infectious Disease • 17 Mar 2026
NatureRelated by Conditionarthritis
Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial
Research Highlights • 26 Jun 2026
Feed Metadata
Source
Frontiers in Immunology
Category
Infectious Disease
Published
26 May 2026
Feed Metadata
Source
Frontiers in Immunology
Category
Infectious Disease
Published
26 May 2026